Rikova K (2008) CST Curation Set: 4329; Year: 2008; Biosample/Treatment: tissue, breast/untreated; Disease: breast cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: 9614, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: 1978

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

T257-p - 4E-T (human) ▲
Modsite: RKRtRRRtAsVKEGI SwissProt Entrez-Gene Orthologous residues 4E‑T (human): T257‑p, 4E‑T iso2 (human): ‑, 4E‑T iso3 (human): T257‑p, 4E‑T (mouse): T256‑p, 4E‑T (rat): T257‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S259-p - 4E-T (human) ▲
Modsite: RtRRRtAsVKEGIVE SwissProt Entrez-Gene Orthologous residues 4E‑T (human): S259‑p, 4E‑T iso2 (human): ‑, 4E‑T iso3 (human): S259‑p, 4E‑T (mouse): S258‑p, 4E‑T (rat): S259‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1161-p - acinus (human) ▲
Modsite: ERRERTRsEREWDRD SwissProt Entrez-Gene Orthologous residues acinus (human): S1161‑p, acinus iso2 (human): S434‑p, acinus iso5 (human): S1148‑p, acinus (mouse): S1160‑p, acinus iso4 (mouse): S1120‑p, acinus iso5 (mouse): S374‑p, acinus (rat): S1161‑p, acinus (cow): S1156‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S627-p - AKAP12 (human) ▲
Modsite: KKRVRRPsEsDKEDE SwissProt Entrez-Gene Orthologous residues AKAP12 (human): S627‑p, AKAP12 iso2 (human): S529‑p, AKAP12 iso3 (human): S522‑p, AKAP12 (mouse): S613‑p, AKAP12 (rat): S614‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S3909-p - ANK2 (human) ▲
Modsite: KIIRRyVssEGTEKE SwissProt Entrez-Gene Orthologous residues ANK2 (human): S3909‑p, ANK2 iso2 (human): S1824‑p, ANK2 iso4 (human): S1815‑p, ANK2 iso5 (human): S507‑p, ANK2 (mouse): S3850‑p, ANK2 iso2 (mouse): S3878‑p, ANK2 iso3 (mouse): S941‑p, ANK2 iso7 (mouse): ‑, ANK2 (rat): S3874‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T1020-p - ARHGAP30 (human) ▲
Modsite: QGVRRtQtCtEGGDy SwissProt Entrez-Gene Orthologous residues ARHGAP30 (human): T1020‑p, ARHGAP30 iso2 (human): T809‑p, ARHGAP30 iso3 (human): T872‑p, ARHGAP30 (mouse): T1020‑p, ARHGAP30 (rat): T1023‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S35-p - ARHGEF11 (human) ▲
Modsite: PsHHRQPsDAsEttG SwissProt Entrez-Gene Orthologous residues ARHGEF11 (human): S35‑p, ARHGEF11 iso2 (human): S35‑p, ARHGEF11 (mouse): S35‑p, ARHGEF11 iso3 (mouse): S35‑p, ARHGEF11 (rat): S51‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S660-p - BFSP1 (human) ▲
Modsite: tKSDKKksGEKSs__ SwissProt Entrez-Gene Orthologous residues BFSP1 (human): S660‑p, BFSP1 (mouse): ‑, BFSP1 (rat): ‑, BFSP1 (cow): L748‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S183-p - BPHL (human) ▲
Modsite: YEGIRDVsKWSERTR SwissProt Entrez-Gene Orthologous residues BPHL (human): S183‑p, BPHL iso2 (human): S166‑p, BPHL (mouse): S183‑p, BPHL (rat): S183‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S572-p - BRDT (human) ▲
Modsite: RELEKYVsACLRKRP SwissProt Entrez-Gene Orthologous residues BRDT (human): S572‑p, BRDT iso2 (human): S585‑p, BRDT (mouse): L568‑p, BRDT (rat): L567‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S260-p - CCT2 (human) ▲
Modsite: GsRVRVDstAkVAEI SwissProt Entrez-Gene Orthologous residues CCT2 (human): S260‑p, CCT2 (mouse): S260‑p, CCT2 (rat): S260‑p, CCT2 (cow): S260‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S233-p - CD2AP (human) ▲
Modsite: kLRtRtsssEtEEKK SwissProt Entrez-Gene Orthologous residues CD2AP (human): S233‑p, CD2AP (mouse): S233‑p, CD2AP (rat): S233‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1504-p - ChaK1 (human) ▲
Modsite: EKIsRRPstEDtHEV SwissProt Entrez-Gene Orthologous residues ChaK1 (human): S1504‑p, ChaK1 (mouse): S1502‑p, ChaK1 (rat): S1501‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S423-p - CPSF7 (human) ▲
Modsite: ssRKRHRsRERsPsR SwissProt Entrez-Gene Orthologous residues CPSF7 (human): S423‑p, CPSF7 iso2 (human): S414‑p, CPSF7 iso3 (human): S466‑p, CPSF7 (mouse): S423‑p, CPSF7 (rat): S414‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S427-p - CPSF7 (human) ▲
Modsite: RHRsRERsPsRsRES SwissProt Entrez-Gene Orthologous residues CPSF7 (human): S427‑p, CPSF7 iso2 (human): S418‑p, CPSF7 iso3 (human): S470‑p, CPSF7 (mouse): S427‑p, CPSF7 (rat): S418‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S429-p - CPSF7 (human) ▲
Modsite: RsRERsPsRsRESSR SwissProt Entrez-Gene Orthologous residues CPSF7 (human): S429‑p, CPSF7 iso2 (human): S420‑p, CPSF7 iso3 (human): S472‑p, CPSF7 (mouse): S429‑p, CPSF7 (rat): S420‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S874-p - CRACD (human) ▲
Modsite: KKKKRHsstGDsADA SwissProt Entrez-Gene Orthologous residues CRACD (human): S874‑p, CRACD (mouse): S935‑p, CRACD (rat): S974‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T238-p - CROP (human) ▲
Modsite: kEKLRKRtEEPDRDE SwissProt Entrez-Gene Orthologous residues CROP (human): T238‑p, CROP (mouse): T238‑p, CROP (rat): T238‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S17-p - CUTC (human) ▲
Modsite: RKRARIPsGKAGAAN SwissProt Entrez-Gene Orthologous residues CUTC (human): S17‑p, CUTC (mouse): S16‑p, CUTC (rat): S16‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1015-p - DENND4A (human) ▲
Modsite: CFRKRHKsDNEtNLQ SwissProt Entrez-Gene Orthologous residues DENND4A (human): S1015‑p, DENND4A iso3 (human): S1058‑p, DENND4A (mouse): S1016‑p, DENND4A (rat): S1016‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T877-p - DMN (human) ▲
Modsite: VQGTRRRtQKDGAVG SwissProt Entrez-Gene Orthologous residues DMN (human): T877‑p, DMN iso2 (human): T877‑p, DMN iso3 (human): ‑, DMN (mouse): K878‑p, DMN (rat): K876‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S105-p - DR1 (human) ▲
Modsite: ALKRRKAssRLENLG SwissProt Entrez-Gene Orthologous residues DR1 (human): S105‑p, DR1 (mouse): S105‑p, DR1 (rat): S105‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1511-p - EHBP1L1 (human) ▲
Modsite: EQRRRKLsRQLsRRE SwissProt Entrez-Gene Orthologous residues EHBP1L1 (human): S1511‑p, EHBP1L1 (mouse): S1704‑p, EHBP1L1 iso2 (mouse): S865‑p, EHBP1L1 iso5 (mouse): S1706‑p, EHBP1L1 (rat): S1687‑p, EHBP1L1 (cow): S1439‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1515-p - EHBP1L1 (human) ▲
Modsite: RKLsRQLsRRERCVL SwissProt Entrez-Gene Orthologous residues EHBP1L1 (human): S1515‑p, EHBP1L1 (mouse): S1708‑p, EHBP1L1 iso2 (mouse): S869‑p, EHBP1L1 iso5 (mouse): S1710‑p, EHBP1L1 (rat): S1691‑p, EHBP1L1 (cow): G1443‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S406-p - EIF4B (human) ▲
Modsite: RPRERHPsWRsEEtQ SwissProt Entrez-Gene Orthologous residues EIF4B (human): S406‑p, EIF4B (mouse): S406‑p, EIF4B (rat): S406‑p, EIF4B (cow): S406‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S422-p - EIF4B (human) ▲
Modsite: RERsRtGsEssQtGt SwissProt Entrez-Gene Orthologous residues EIF4B (human): S422‑p, EIF4B (mouse): S422‑p, EIF4B (rat): S422‑p, EIF4B (cow): S422‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S442-p - EIF4B (human) ▲
Modsite: RNARRREsEksLENE SwissProt Entrez-Gene Orthologous residues EIF4B (human): S442‑p, EIF4B (mouse): S442‑p, EIF4B (rat): S442‑p, EIF4B (cow): S442‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S461-p - ELMSAN1 (human) ▲
Modsite: trRRRRAsQEANLLt SwissProt Entrez-Gene Orthologous residues ELMSAN1 (human): S461‑p, ELMSAN1 (mouse): S456‑p, ELMSAN1 (rat): S456‑p, ELMSAN1 (cow): S461‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S160-p - EML1 (human) ▲
Modsite: GNRNRtGstsSSSSG SwissProt Entrez-Gene Orthologous residues EML1 (human): S160‑p, EML1 iso3 (human): S179‑p, EML1 (mouse): S159‑p, EML1 iso4 (mouse): S128‑p, EML1 (rat): S159‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T89-p - endofin (human) ▲
Modsite: EKTLkGLtsIQNEkN SwissProt Entrez-Gene Orthologous residues endofin (human): T89‑p, endofin (mouse): T86‑p, endofin (rat): T88‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T332-p - Ezrin (human) ▲
Modsite: TEKKRREtVEREkEQ SwissProt Entrez-Gene Orthologous residues Ezrin (human): T332‑p, Ezrin (mouse): T332‑p, Ezrin (rat): T332‑p, Ezrin (chicken): T332‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1048-p - FAM184B (human) ▲
Modsite: EVQQKQGsPHQEWFT SwissProt Entrez-Gene Orthologous residues FAM184B (human): S1048‑p, FAM184B (mouse): S930‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

S2152-p - FLNA (human) ▲
Modsite: tRRRRAPsVANVGsH SwissProt Entrez-Gene Orthologous residues FLNA (human): S2152‑p, FLNA iso2 (human): S2144‑p, FLNA (mouse): S2152‑p, FLNA (rat): S2144‑p, FLNA (cow): S2155‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T30-p - FMIP (human) ▲
Modsite: GkRNRsDtEQEGKYy SwissProt Entrez-Gene Orthologous residues FMIP (human): T30‑p, FMIP (mouse): T30‑p, FMIP (rat): T30‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S878-p - GOLGA3 (human) ▲
Modsite: AtRKRLDsELKELRQ SwissProt Entrez-Gene Orthologous residues GOLGA3 (human): S878‑p, GOLGA3 iso2 (human): S878‑p, GOLGA3 (mouse): S874‑p, GOLGA3 (rat): S834‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S784-p - GTF2I (human) ▲
Modsite: GVPFRRPstFGIPRL SwissProt Entrez-Gene Orthologous residues GTF2I (human): S784‑p, GTF2I iso2 (human): S743‑p, GTF2I iso4 (human): S763‑p, GTF2I (mouse): S784‑p, GTF2I iso8 (mouse): S744‑p, GTF2I (rat): S765‑p, GTF2I iso2 (rat): S699‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S743-p - GTF2I iso2 (human) ▲
Modsite: GVPFRRPstFGIPRL SwissProt Entrez-Gene Orthologous residues GTF2I (human): S784‑p, GTF2I iso2 (human): S743‑p, GTF2I iso4 (human): S763‑p, GTF2I (mouse): S784‑p, GTF2I iso8 (mouse): S744‑p, GTF2I (rat): S765‑p, GTF2I iso2 (rat): S699‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1245-p - HBXAP (human) ▲
Modsite: RVHKRRLsssEsEEs SwissProt Entrez-Gene Orthologous residues HBXAP (human): S1245‑p, HBXAP iso2 (human): S1214‑p, HBXAP iso3 (human): S993‑p, HBXAP (mouse): S1249‑p, HBXAP (rat): S1254‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T1305-p - HBXAP (human) ▲
Modsite: KRLHRIEtDEEEsCD SwissProt Entrez-Gene Orthologous residues HBXAP (human): T1305‑p, HBXAP iso2 (human): T1274‑p, HBXAP iso3 (human): T1053‑p, HBXAP (mouse): T1308‑p, HBXAP (rat): T1313‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S87-p - HN1 (human) ▲
Modsite: sGLQRRNssEAssGD SwissProt Entrez-Gene Orthologous residues HN1 (human): S87‑p, HN1 iso2 (human): S87‑p, HN1 (mouse): S87‑p, HN1 (rat): S82‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S720-p - IWS1 (human) ▲
Modsite: PQRRRMNstGGQtPR SwissProt Entrez-Gene Orthologous residues IWS1 (human): S720‑p, IWS1 iso2 (human): S395‑p, IWS1 iso3 (human): S513‑p, IWS1 (mouse): S667‑p, IWS1 (rat): S666‑p, IWS1 (cow): S723‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S458-p - lamin A/C (human) ▲
Modsite: FVRLRNksNEDQsMG SwissProt Entrez-Gene Orthologous residues lamin A/C (human): S458‑p, lamin A/C iso2 (human): S458‑p, lamin A/C iso3 (human): S458‑p, lamin A/C (mouse): S458‑p, lamin A/C iso3 (mouse): S346‑p, lamin A/C (rat): S458‑p, lamin A/C (cow): S458‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S458-p - lamin A/C iso2 (human) ▲
Modsite: FVRLRNKsNEDQSMG SwissProt Entrez-Gene Orthologous residues lamin A/C (human): S458‑p, lamin A/C iso2 (human): S458‑p, lamin A/C iso3 (human): S458‑p, lamin A/C (mouse): S458‑p, lamin A/C iso3 (mouse): S346‑p, lamin A/C (rat): S458‑p, lamin A/C (cow): S458‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S610-p - LMBRD2 (human) ▲
Modsite: yGHNREDstRNRNIH SwissProt Entrez-Gene Orthologous residues LMBRD2 (human): S610‑p, LMBRD2 (mouse): S610‑p, LMBRD2 (rat): S610‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T230-p - LMOD1 (human) ▲
Modsite: VKGERRNtDtRKEGE SwissProt Entrez-Gene Orthologous residues LMOD1 (human): T230‑p, LMOD1 (mouse): T228‑p, LMOD1 (rat): T229‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S252-p - LSP1 (human) ▲
Modsite: PKLARQAsIELPsMA SwissProt Entrez-Gene Orthologous residues LSP1 (human): S252‑p, LSP1 iso2 (human): S190‑p, LSP1 iso3 (human): S380‑p, LSP1 (mouse): S243‑p, LSP1 iso3 (mouse): S235‑p, LSP1 (rat): S244‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S276-p - LYAR (human) ▲
Modsite: GKRKRRHsEVETDsk SwissProt Entrez-Gene Orthologous residues LYAR (human): S276‑p, LYAR (mouse): S285‑p, LYAR (rat): S283‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Species studied:  human

T507-p - MARK3 (human) ▲
Modsite: GGMtRRNtyVCsERT SwissProt Entrez-Gene Orthologous residues MARK3 (human): T507‑p, MARK3 iso3 (human): T507‑p, MARK3 iso6 (human): T491‑p, MARK3 iso7 (human): T514‑p, MARK3 (mouse): T507‑p, MARK3 (rat): T507‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T507-p - MARK3 iso3 (human) ▲
Modsite: GGMTRRNtyVCSERT SwissProt Entrez-Gene Orthologous residues MARK3 (human): T507‑p, MARK3 iso3 (human): T507‑p, MARK3 iso6 (human): T491‑p, MARK3 iso7 (human): T514‑p, MARK3 (mouse): T507‑p, MARK3 (rat): T507‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T491-p - MARK3 iso6 (human) ▲
Modsite: GGMTRRNtyVCSERT SwissProt Entrez-Gene Orthologous residues MARK3 (human): T507‑p, MARK3 iso3 (human): T507‑p, MARK3 iso6 (human): T491‑p, MARK3 iso7 (human): T514‑p, MARK3 (mouse): T507‑p, MARK3 (rat): T507‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T5123-p - midasin (human) ▲
Modsite: RVHKRLRtVDtDsHA SwissProt Entrez-Gene Orthologous residues midasin (human): T5123‑p, midasin (mouse): T5120‑p, midasin (rat): T5118‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S546-p - MORC3 (human) ▲
Modsite: NsLkRRLstRssILN SwissProt Entrez-Gene Orthologous residues MORC3 (human): S546‑p, MORC3 (mouse): G549‑p, MORC3 (rat): S286‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S560-p - MORC3 (human) ▲
Modsite: NAkNRRLssQFENSV SwissProt Entrez-Gene Orthologous residues MORC3 (human): S560‑p, MORC3 (mouse): S563‑p, MORC3 (rat): S300‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S561-p - MORC3 (human) ▲
Modsite: AkNRRLssQFENSVY SwissProt Entrez-Gene Orthologous residues MORC3 (human): S561‑p, MORC3 (mouse): N564‑p, MORC3 (rat): N301‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T496-p - MPHOSPH8 (human) ▲
Modsite: sLKERRNtRDEtDtW SwissProt Entrez-Gene Orthologous residues MPHOSPH8 (human): T496‑p, MPHOSPH8 iso2 (human): T496‑p, MPHOSPH8 (mouse): T494‑p, MPHOSPH8 (rat): T487‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1203-p - MTUS1 (human) ▲
Modsite: MAIsRQLstEQAVLQ SwissProt Entrez-Gene Orthologous residues MTUS1 (human): S1203‑p, MTUS1 iso2 (human): S1149‑p, MTUS1 iso3 (human): S369‑p, MTUS1 iso6 (human): S450‑p, MTUS1 (mouse): S1143‑p, MTUS1 (rat): S373‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S507-p - MYPT1 (human) ▲
Modsite: tIPRRLAstsDIEEK SwissProt Entrez-Gene Orthologous residues MYPT1 (human): S507‑p, MYPT1 iso2 (human): S507‑p, MYPT1 iso3 (human): S507‑p, MYPT1 iso4 (human): S507‑p, MYPT1 (mouse): S507‑p, MYPT1 (rat): S507‑p, MYPT1 (pig): S507‑p, MYPT1 (chicken): S502‑p, MYPT1 (cow): S507‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S668-p - MYPT1 (human) ▲
Modsite: EVRERRRsyLtPVRD SwissProt Entrez-Gene Orthologous residues MYPT1 (human): S668‑p, MYPT1 iso2 (human): S668‑p, MYPT1 iso3 (human): S612‑p, MYPT1 iso4 (human): S609‑p, MYPT1 (mouse): S666‑p, MYPT1 (rat): S669‑p, MYPT1 (pig): S668‑p, MYPT1 (chicken): S667‑p, MYPT1 (cow): S668‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S149-p - N-PAC (human) ▲
Modsite: EGKKRVssGssERGS SwissProt Entrez-Gene Orthologous residues N‑PAC (human): S149‑p, N‑PAC iso2 (human): S149‑p, N‑PAC (mouse): S149‑p, N‑PAC iso3 (mouse): S149‑p, N‑PAC (rat): S149‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T346-p - NDRG1 (human) ▲
Modsite: GtRsRsHtsEGtRsR SwissProt Entrez-Gene Orthologous residues NDRG1 (human): T346‑p, NDRG1 iso2 (human): T280‑p, NDRG1 iso3 (human): T265‑p, NDRG1 (mouse): T346‑p, NDRG1 (rat): T346‑p, NDRG1 (cow): T346‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T356-p - NDRG1 (human) ▲
Modsite: GtRsRsHtsEGtRsR SwissProt Entrez-Gene Orthologous residues NDRG1 (human): T356‑p, NDRG1 iso2 (human): T290‑p, NDRG1 iso3 (human): T275‑p, NDRG1 (mouse): T356‑p, NDRG1 (rat): T356‑p, NDRG1 (cow): T356‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T366-p - NDRG1 (human) ▲
Modsite: GtRsRsHtsEGAHLD SwissProt Entrez-Gene Orthologous residues NDRG1 (human): T366‑p, NDRG1 iso2 (human): T300‑p, NDRG1 iso3 (human): T285‑p, NDRG1 (mouse): T366‑p, NDRG1 (rat): T366‑p, NDRG1 (cow): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

S290-p - NIFK (human) ▲
Modsite: sRKKRRRssNQ____ SwissProt Entrez-Gene Orthologous residues NIFK (human): S290‑p, NIFK (mouse): K314‑p, NIFK (rat): K268‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S104-p - PEA-15 (human) ▲
Modsite: tkLtRIPsAKKykDI SwissProt Entrez-Gene Orthologous residues PEA‑15 (human): S104‑p, PEA‑15 iso2 (human): S125‑p, PEA‑15 (mouse): S104‑p, PEA‑15 (rat): S104‑p, PEA‑15 (hamster): S104‑p, PEA‑15 (cow): S104‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S116-p - PEA-15 (human) ▲
Modsite: kDIIRQPsEEEIIKL SwissProt Entrez-Gene Orthologous residues PEA‑15 (human): S116‑p, PEA‑15 iso2 (human): S137‑p, PEA‑15 (mouse): S116‑p, PEA‑15 (rat): S116‑p, PEA‑15 (hamster): S116‑p, PEA‑15 (cow): S116‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T774-p - PKN1 (human) ▲
Modsite: GyGDRtstFCGtPEF SwissProt Entrez-Gene Orthologous residues PKN1 (human): T774‑p, PKN1 iso2 (human): T780‑p, PKN1 (mouse): T778‑p, PKN1 (rat): T778‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T816-p - PKN2 (human) ▲
Modsite: GyGDRtstFCGtPEF SwissProt Entrez-Gene Orthologous residues PKN2 (human): T816‑p, PKN2 iso2 (human): T800‑p, PKN2 (mouse): T815‑p, PKN2 (rat): T817‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1105-p - PLCB3 (human) ▲
Modsite: LDRKRHNsIsEAKMR SwissProt Entrez-Gene Orthologous residues PLCB3 (human): S1105‑p, PLCB3 iso2 (human): S1038‑p, PLCB3 (mouse): S1105‑p, PLCB3 (rat): S1105‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1248-p - PLCG1 (human) ▲
Modsite: HGrAREGsFEsRyQQ SwissProt Entrez-Gene Orthologous residues PLCG1 (human): S1248‑p, PLCG1 iso2 (human): S1249‑p, PLCG1 (mouse): S1248‑p, PLCG1 (rat): S1248‑p, PLCG1 (cow): S1249‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T114-p - pleckstrin (human) ▲
Modsite: QKFARKstRRsIRLP SwissProt Entrez-Gene Orthologous residues pleckstrin (human): T114‑p, pleckstrin iso100 (human): T114‑p, pleckstrin (mouse): T114‑p, pleckstrin (rat): T114‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S88-p - PLM (human) ▲
Modsite: RssIRRLstRRR___ SwissProt Entrez-Gene Orthologous residues PLM (human): S88‑p, PLM (mouse): S88‑p, PLM (rat): S88‑p, PLM (dog): S88‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T89-p - PLM (human) ▲
Modsite: ssIRRLstRRR____ SwissProt Entrez-Gene Orthologous residues PLM (human): T89‑p, PLM (mouse): S89‑p, PLM (rat): T89‑p, PLM (dog): T89‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S84-p - PPEF-1 (human) ▲
Modsite: ELELRNQsLESEQDM SwissProt Entrez-Gene Orthologous residues PPEF‑1 (human): S84‑p, PPEF‑1 iso3 (human): S84‑p, PPEF‑1 (mouse): I84‑p, PPEF‑1 (rat): L84‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S376-p - PPIG (human) ▲
Modsite: AQRMRVssGERWIKG SwissProt Entrez-Gene Orthologous residues PPIG (human): S376‑p, PPIG (mouse): S374‑p, PPIG (rat): S374‑p, PPIG (cow): S376‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S839-p - PPP1R12B (human) ▲
Modsite: ERLsRLEsGGsNPtt SwissProt Entrez-Gene Orthologous residues PPP1R12B (human): S839‑p, PPP1R12B iso3 (human): S65‑p, PPP1R12B iso6 (human): S900‑p, PPP1R12B (mouse): S833‑p, PPP1R12B (rat): S834‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1242-p - PRRC2C (human) ▲
Modsite: PLRQREEsEtRsEss SwissProt Entrez-Gene Orthologous residues PRRC2C (human): S1242‑p, PRRC2C iso2 (human): S999‑p, PRRC2C iso3 (human): S1242‑p, PRRC2C iso4 (human): S1242‑p, PRRC2C iso7 (human): S1244‑p, PRRC2C (mouse): S1215‑p, PRRC2C iso5 (mouse): S1215‑p, PRRC2C (rat): S1231‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S29-p - RALBP1 (human) ▲
Modsite: sGLtRtPssEEIsPt SwissProt Entrez-Gene Orthologous residues RALBP1 (human): S29‑p, RALBP1 (mouse): S29‑p, RALBP1 (rat): S29‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1422-p - RBBP6 (human) ▲
Modsite: NPEKRKNsTQPEKES SwissProt Entrez-Gene Orthologous residues RBBP6 (human): S1422‑p, RBBP6 iso2 (human): S1388‑p, RBBP6 (mouse): G1423‑p, RBBP6 iso2 (mouse): G1389‑p, RBBP6 (rat): S1421‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S14-p - RBM34 (human) ▲
Modsite: SKRKRKRsVQEGENP SwissProt Entrez-Gene Orthologous residues RBM34 (human): S14‑p, RBM34 (mouse): G13‑p, RBM34 (rat): G13‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S709-p - REPS1 (human) ▲
Modsite: PVRRRLksEDELRPE SwissProt Entrez-Gene Orthologous residues REPS1 (human): S709‑p, REPS1 iso2 (human): S618‑p, REPS1 iso3 (human): S708‑p, REPS1 iso4 (human): S682‑p, REPS1 (mouse): S708‑p, REPS1 iso3 (mouse): S629‑p, REPS1 (rat): S708‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S308-p - RFX5 (human) ▲
Modsite: ArGERkKsVVESsAP SwissProt Entrez-Gene Orthologous residues RFX5 (human): S308‑p, RFX5 (mouse): S308‑p, RFX5 (rat): S308‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1184-p - RIF1 (human) ▲
Modsite: LISSRKtstECAsSt SwissProt Entrez-Gene Orthologous residues RIF1 (human): S1184‑p, RIF1 iso2  (human): S1184‑p, RIF1 (mouse): S1180‑p, RIF1 (rat): S1040‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S104-p - RSRC2 (human) ▲
Modsite: KGRERLNssENGEDR SwissProt Entrez-Gene Orthologous residues RSRC2 (human): S104‑p, RSRC2 iso2 (human): S56‑p, RSRC2 (mouse): S103‑p, RSRC2 iso2 (mouse): S45‑p, RSRC2 (rat): S45‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S19-p - RTL1 (human) ▲
Modsite: MMEHKNPsSKQMESS SwissProt Entrez-Gene Orthologous residues RTL1 (human): S19‑p, RTL1 (mouse): S19‑p, RTL1 (rat): S19‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S235-p - S6 (human) ▲
Modsite: IAKRRRLssLRAsts SwissProt Entrez-Gene Orthologous residues S6 (human): S235‑p, S6 (mouse): S235‑p, S6 (rat): S235‑p, S6 (fruit fly): A234‑p, S6 (cow): S235‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S236-p - S6 (human) ▲
Modsite: AKRRRLssLRAstsK SwissProt Entrez-Gene Orthologous residues S6 (human): S236‑p, S6 (mouse): S236‑p, S6 (rat): S236‑p, S6 (fruit fly): S235‑p, S6 (cow): S236‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T241-p - S6 (human) ▲
Modsite: LssLRAstsKsEssQ SwissProt Entrez-Gene Orthologous residues S6 (human): T241‑p, S6 (mouse): T241‑p, S6 (rat): T241‑p, S6 (fruit fly): K240‑p, S6 (cow): T241‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S830-p - SEMA4B (human) ▲
Modsite: RPRVRLGsEIRDsVV SwissProt Entrez-Gene Orthologous residues SEMA4B (human): S830‑p, SEMA4B iso3 (human): S830‑p, SEMA4B (mouse): S816‑p, SEMA4B (rat): S814‑p

S435-p - SFRS12 (human) ▲
Modsite: ERRERERstsMRKss SwissProt Entrez-Gene Orthologous residues SFRS12 (human): S435‑p, SFRS12 iso2 (human): S551‑p, SFRS12 (mouse): S420‑p, SFRS12 iso2 (mouse): S536‑p, SFRS12 (rat): S420‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S437-p - SFRS12 (human) ▲
Modsite: RERERstsMRKssND SwissProt Entrez-Gene Orthologous residues SFRS12 (human): S437‑p, SFRS12 iso2 (human): S553‑p, SFRS12 (mouse): S422‑p, SFRS12 iso2 (mouse): S538‑p, SFRS12 (rat): S422‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S442-p - SFRS12 (human) ▲
Modsite: stsMRKssNDRDGKE SwissProt Entrez-Gene Orthologous residues SFRS12 (human): S442‑p, SFRS12 iso2 (human): S558‑p, SFRS12 (mouse): S427‑p, SFRS12 iso2 (mouse): S543‑p, SFRS12 (rat): S427‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T303-p - SGTA (human) ▲
Modsite: RsQIRsRtPsAsNDD SwissProt Entrez-Gene Orthologous residues SGTA (human): T303‑p, SGTA (mouse): T305‑p, SGTA (rat): T304‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S597-p - SRRP130 (human) ▲
Modsite: KIRDRRRsNRNsIER SwissProt Entrez-Gene Orthologous residues SRRP130 (human): S597‑p, SRRP130 (mouse): S597‑p, SRRP130 (rat): S597‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S126-p - STX7 (human) ▲
Modsite: VARVRAssRVsGsFP SwissProt Entrez-Gene Orthologous residues STX7 (human): S126‑p, STX7 iso2 (human): S126‑p, STX7 (mouse): S126‑p, STX7 (rat): S126‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T107-p - SUN2 (human) ▲
Modsite: RVRRRrGtGGsEssR SwissProt Entrez-Gene Orthologous residues SUN2 (human): T107‑p, SUN2 iso2 (human): T107‑p, SUN2 (mouse): T117‑p, SUN2 (rat): T116‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S363-p - SYNPO2 (human) ▲
Modsite: ARLRRsEsLsEKQVK SwissProt Entrez-Gene Orthologous residues SYNPO2 (human): S363‑p, SYNPO2 iso2 (human): S363‑p, SYNPO2 (mouse): S353‑p, SYNPO2 iso3 (mouse): S353‑p, SYNPO2 (rat): S357‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1238-p - TBC1D9B (human) ▲
Modsite: KKVERQFstAsDHEQ SwissProt Entrez-Gene Orthologous residues TBC1D9B (human): S1238‑p, TBC1D9B iso2 (human): S1221‑p, TBC1D9B (mouse): S1251‑p, TBC1D9B (rat): S1250‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1221-p - TBC1D9B iso2 (human) ▲
Modsite: KKVERQFsTASDHEQ SwissProt Entrez-Gene Orthologous residues TBC1D9B (human): S1238‑p, TBC1D9B iso2 (human): S1221‑p, TBC1D9B (mouse): S1251‑p, TBC1D9B (rat): S1250‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S899-p - tensin 1 iso1 (human) ▲
Modsite: PLRRRAAsDGQyENQ SwissProt Entrez-Gene Orthologous residues tensin 1 (human): S1024‑p, tensin 1 iso1 (human): S899‑p, tensin 1 iso2 (human): ‑, tensin 1 (mouse): S1054‑p, tensin 1 (rat): S1073‑p, tensin 1 (cow): S902‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S324-p - VASP (human) ▲
Modsite: LPRMkssssVttSEt SwissProt Entrez-Gene Orthologous residues VASP (human): S324‑p, VASP (mouse): S319‑p, VASP (rat): S320‑p Characterization Methods used to characterize site in vivo:  mass spectrometry